etoposide has been researched along with Plasma Cell Tumor in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Barlogie, B; Mouhieddine, TH; Teruya-Feldstein, J | 1 |
| Anderson, KC; Badros, A; Beksac, M; Bladé, J; Caers, J; Cavo, M; Dimopoulos, MA; Dispenzieri, A; Einsele, H; Engelhardt, M; Fernández de Larrea, C; Gahrton, G; Gay, F; Hájek, R; Hungria, V; Jurczyszyn, A; Kröger, N; Kyle, RA; Leal da Costa, F; Leleu, X; Lentzsch, S; Mateos, MV; Merlini, G; Mohty, M; Moreau, P; Rasche, L; Reece, D; Richardson, PG; Rosiñol, L; Sezer, O; Sonneveld, P; Usmani, SZ; Van de Donk, NWCJ; Vanderkerken, K; Vesole, DH; Waage, A; Zamagni, E; Zweegman, S | 1 |
| Choi, E; Meehan, KR; Tsui, EW | 1 |
| Pinkhas, D; Toocheck, C | 1 |
| Cavenagh, J; Ingram, W; Quinn, J; Smith, D; Stevens, J; Yong, K | 1 |
| Balayre, S; Dighiero, P; Gicquel, JJ; Mercie, M | 1 |
| Dalton, WS; Engel, R; Gump, JL; Hazlehurst, L; Sullivan, DM; Valkov, NI | 1 |
| Anastasiadis, AG; Argyropoulou, P; Bourikas, G; Kaloutsi, V; Margaritis, D; Pantelidou, D; Prassopoulos, P; Tsatalas, C | 1 |
| Ganjoo, RK; Malpas, JS; Plowman, PN | 1 |
1 review(s) available for etoposide and Plasma Cell Tumor
| Article | Year |
|---|---|
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Cisplatin; Cyclophosphamide; Dexamethasone; Disease Management; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Multiple Myeloma; Plasmacytoma; Prognosis; Transplantation, Autologous | 2021 |
8 other study(ies) available for etoposide and Plasma Cell Tumor
| Article | Year |
|---|---|
Hemophagocytic relapsed intramedullary plasmacytoma.
Topics: Adult; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Bortezomib; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Magnetic Resonance Imaging; Melphalan; Neoplasm Recurrence, Local; Oligopeptides; Plasmacytoma; Positron Emission Tomography Computed Tomography; Pubic Bone; Rare Diseases; Stem Cell Transplantation; Thalidomide; Transplantation, Autologous; Treatment Outcome | 2020 |
New Painful Nodules in a Patient With Multiple Myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cancer Pain; Cisplatin; Cyclophosphamide; Dexamethasone; Diagnosis, Differential; Etoposide; Female; Humans; Middle Aged; Multiple Myeloma; Neoplasm Staging; Plasmacytoma; Positron Emission Tomography Computed Tomography; Treatment Outcome; Ultrasonography, Interventional | 2017 |
Treatment of relapsed multiple myeloma complicated by cardiac extramedullary plasmacytoma with D-PACE chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Heart Neoplasms; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Plasmacytoma; Positron-Emission Tomography | 2018 |
Myeloma presenting during pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cesarean Section; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Contraindications; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Humans; Hypercalcemia; Idarubicin; Infant, Newborn; Lenalidomide; Male; Melphalan; Methylprednisolone; Multiple Myeloma; Myeloma Proteins; Osteolysis; Plasmacytoma; Postpartum Period; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pyrazines; Remission Induction; Spinal Cord Compression; Thalidomide; Thoracic Vertebrae; Transplantation, Autologous | 2014 |
[Orbital extension of sinus plasmacytoma secondarily transforming into multiple myeloma: a case study].
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Dexamethasone; Diplopia; Doxorubicin; Ethmoid Sinus; Etoposide; Exophthalmos; Humans; Male; Maxillary Sinus; Maxillary Sinus Neoplasms; Methylprednisolone Hemisuccinate; Multiple Myeloma; Orbit; Orbital Neoplasms; Paranasal Sinus Neoplasms; Plasmacytoma; Tomography, X-Ray Computed; Treatment Outcome; Vincristine; Visual Acuity | 2004 |
The cytoplasmic trafficking of DNA topoisomerase IIalpha correlates with etoposide resistance in human myeloma cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Line, Tumor; Cell Nucleus; Comet Assay; Cytoplasm; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Electrophoresis, Gel, Two-Dimensional; Etoposide; Fatty Acids, Unsaturated; Flow Cytometry; HL-60 Cells; Humans; Microscopy, Fluorescence; Mitoxantrone; Multiple Myeloma; Plasmacytoma; Protein Transport; Subcellular Fractions | 2004 |
Successful treatment of lymph node extramedullary plasmacytoma with bortezomib.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Injections, Intravenous; Lymph Nodes; Male; Middle Aged; Peritoneal Neoplasms; Plasmacytoma; Pyrazines; Radiotherapy Dosage; Stem Cell Transplantation; Tomography, X-Ray Computed; Transplantation, Autologous | 2006 |
Solitary plasmacytoma of bone--a rare disorder with an unusual evolution.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Liver Neoplasms; Multiple Myeloma; Plasmacytoma; Spinal Neoplasms; Splenectomy; Splenic Neoplasms; Vincristine | 1993 |